Quick Takeaways: Why It Matters? Antech’s peer-reviewed Accuplex findings could strengthen its competitive position in canine vector-borne disease diagnostics, particularly for Ehrlichia antibody detection, where it outperformed IDEXX’s SNAP 4Dx Plus in this study. Independent ...
Quick Takeaways: Why It Matters? The Bioguard agreement deepens KVP SafePath’s diagnostics pipeline with access to a broad reagent/IP library and a faster path to USDA‑licensed 4DX/3DX panels, positioning the company to enter a >$500 million North America...
